Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...

CALIFORNIA, USA — Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom. Beginning Jan. 1, 2026 ...

California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...

The state’s CalRx Insulin Glargine will be available to consumers for a suggested retail price of $55 or less per five-pack of pens beginning Jan. 1, 2026. The insulin glargine pen agreement with ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...

Read full article: Power stays on at Detroit’s Leland House apartments after owner makes emergency payment to DTE The Michigan Public Service Commission declined to act on power-contract requests ...

In a challenge to the pharmaceutical industry, Gov. Gavin Newsom on Thursday announced a plan to offer $11 insulin pens through the state's prescription program, far below market cost. Beginning Jan.

Dr. Cook answers the question: 'Pros of Giving Insulin By Pen/Syringe?' — -- Question:What are the pros and cons of giving insulin by syringe and by pen? Answer:Well the pen-versus-syringe ...

CVS will pay for dispensing and billing health care plans including Tricare for more insulin than was prescribed, according to a lawsuit settlement.

Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded ...